Utilizing exclusive, patented LipiSperse® technology means that resveratrol’s normally limited ability to dissolve in aqueous environments (such as the stomach), is enhanced and can disperse freely, increasing VeriSperse®’s bioavailability and therefore efficacy as it becomes more readily available.
VeriSperse® is a trademark of Pharmako Biotechnologies Pty Ltd.
VeriSperse® has an equilibrium established between the LipiSperse® on the powder surface and the solution. Repulsive forces between the particles prevent agglomeration or aggregation: allowing VeriSperse® to have proper particle dispersion. Proper dispersion offers advantages in absorption, dosage requirements, efficacy and final product quality.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.